Observational studyViruses2023

Effectiveness of Oral Nirmatrelvir/Ritonavir vs. Intravenous Three-Day Remdesivir in Preventing Progression to Severe COVID-19: A Single-Center, Prospective, Comparative, Real-Life Study.

Dimitrios Basoulis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.